HPSE and neoplasm: The mechanism of action of these HS-mimetics is primarily mediated via inhibition of heparanase-mediated angiogenesis and metastasis, competitive binding with growth factors, and/or activation of tumor-suppressing immune cells (e.g., natural killer and dendritic cells) [165,169].